Impact of Vaginal Estradiol on the Genitourinary Syndrome of Menopause, Vaginal Microbiome and Mucosal Immune Mediators in Women Living With HIV
The favorable response to estradiol suggests that treatment perhaps initiated earlier may be beneficial for GSM in WWH and should be studied in larger clinical trials.
Authors
- Jessica Atrio (ORCID: https://orcid.org/0000-0002-3505-643X)
- Jessica McWalters
- Libusha Kelly (ORCID: https://orcid.org/0000-0002-7303-1022)
- Aakash Mahant Mahant (ORCID: https://orcid.org/0000-0002-0530-122X)
- Betsy C. Herold (ORCID: https://orcid.org/0000-0001-9974-0786)
- Tao Wang (ORCID: https://orcid.org/0000-0003-1359-8913)
- Agnes Colanta
- Deborah Gustafson (ORCID: https://orcid.org/0000-0001-9556-8560)
- J.C. Connolly (ORCID: https://orcid.org/0009-0002-8917-2353)
- Kerry Murphy (ORCID: https://orcid.org/0000-0001-5272-333X)
- Matthew S. Gromisch (ORCID: https://orcid.org/0009-0006-2701-1115)
- Marla J. Keller (ORCID: https://orcid.org/0000-0003-0417-4000)
- Kathryn Anastos (ORCID: https://orcid.org/0000-0002-0769-6405)
- H. Estrella (ORCID: https://orcid.org/0009-0001-8045-4103)
- Shweta Gera
- Howard Minkoff
- Antonio Cajigas
Institutions
- Albert Einstein College of Medicine (US)
- SUNY Downstate Health Sciences University (US)
- Drexel University (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1093/cid/ciaf669
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00